Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
This article compares retirement index funds and target date funds to help you decide which aligns with your goals and timeline.
26,044 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Pony AI's Q1 2026 earnings transcript is a pivotal moment for investors. This article breaks down the key numbers, th...
Savers face a rate tug-of-war in 2026 as money market accounts high yields compete with high yield savings accounts. ...
Broadcom climbs about 5% to around $390 after Apple expands its multiyear chip deal. Intel and AMD drift lower as inv...
Wall Street and crypto traders watch a quiet moment for Bitcoin as geopolitical tensions cool and ETF inflows grow. T...
Could a bold thesis around Oklo Inc. unlock life-changing gains? This forward-looking guide breaks down why nuclear e...
Nvidia still dominates AI hardware, but the stock's sparkle has cooled. This article breaks down the three big reason...
A little-known tax lane lets some investors pocket long-term gains tax-free. As 2026 unfolds, careful planning can un...
GM is navigating a tepid U.S. EV market, yet the company is pivoting toward energy storage and software. This article...
ASML shares swung after reports of China’s push to develop a domestic EUV rival. Yet analysts say the technical and s...
Bittensor's TAO aims to blend AI training services with blockchain incentives. After a sharp rally, investors wonder ...
A morning surge in AeroVironment stock popped today after reports of potential U.S. drone subsidies. This guide unpac...